OTC Markets OTCPK - Delayed Quote USD

PharmChem, Inc. (PCHM)

Compare
3.2700
-0.1300
(-3.82%)
At close: 3:24:56 PM EDT
Loading Chart for PCHM
  • Previous Close 3.4000
  • Open 3.3900
  • Bid 3.2700 x 28000
  • Ask 3.3800 x --
  • Day's Range 3.2500 - 3.3900
  • 52 Week Range 2.5100 - 4.0000
  • Volume 1,600
  • Avg. Volume 3,216
  • Market Cap (intraday) 15.111M
  • Beta (5Y Monthly) 0.69
  • PE Ratio (TTM) --
  • EPS (TTM) -192.6700
  • Earnings Date Apr 28, 2025 - May 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Oct 10, 2024
  • 1y Target Est --

PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.

www.pharmchek.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PCHM

View More

Performance Overview: PCHM

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PCHM
6.86%
S&P 500 (^GSPC)
13.73%

1-Year Return

PCHM
27.09%
S&P 500 (^GSPC)
1.42%

3-Year Return

PCHM
18.51%
S&P 500 (^GSPC)
10.72%

5-Year Return

PCHM
18.25%
S&P 500 (^GSPC)
103.89%

Compare To: PCHM

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PCHM

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    15.71M

  • Enterprise Value

    15.71M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -7.94%

  • Return on Assets (ttm)

    -5.37%

  • Return on Equity (ttm)

    -23.67%

  • Revenue (ttm)

    25.73M

  • Net Income Avi to Common (ttm)

    -2.04M

  • Diluted EPS (ttm)

    -192.6700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    626k

  • Total Debt/Equity (mrq)

    37.04%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: PCHM

View More

Company Insights: PCHM

Research Reports: PCHM

View More

People Also Watch